MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 5904-5913

  Sullivan, Ryan P ^a   Fogel, Leslie A ^a   Leong, Jeffrey W ^a   Schneider, Stephanie E ^a   Wong, Rachel ^a   Romee, Rizwan ^a   Thai, To Ha ^b   Sexl, Veronika ^c   Matkovich, Scot J ^a   Dorn II, Gerald W ^a   French, Anthony R ^a   Fehniger, Todd A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 155; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84890361708     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301950     Document Type: Article

References (43)

1. Yokoyama, W. M., S. Kim, and A. R. French. 2004. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22: 405-429.
2. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510.
3. Di Santo, J. P. 2006. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24: 257-286.
4. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
5. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
6. Orange, J. S. 2008. Formation and function of the lytic NK-cell immunological synapse. Nat. Rev. Immunol. 8: 713-725.
7. Tripathy, S. K., P. A. Keyel, L. Yang, J. T. Pingel, T. P. Cheng, A. Schneeberger, and W. M. Yokoyama. 2008. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205: 1829-1841.
8. Elliott, J. M., J. A. Wahle, and W. M. Yokoyama. 2010. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J. Exp. Med. 207: 2073-2079.
9. Höglund, P., and P. Brodin. 2010. Current perspectives of natural killer cell education by MHC class I molecules. Nat. Rev. Immunol. 10: 724-734.
10. Long, E. O., H. S. Kim, D. Liu, M. E. Peterson, and S. Rajagopalan. 2013. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31: 227-258.
11. Hesslein, D. G. T., and L. L. Lanier. 2011. Transcriptional control of natural killer cell development and function. Adv. Immunol. 109: 45-85.
12. Ramirez, K., and B. L. Kee. 2010. Multiple hats for natural killers. Curr. Opin. Immunol. 22: 193-198.
13. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
14. Garzon, R., G. A. Calin, and C. M. Croce. 2009. MicroRNAs in Cancer. Annu. Rev. Med. 60: 167-179.
15. O'Connell, R. M., D. S. Rao, and D. Baltimore. 2012. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30: 295-312.
16. Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9: 839-845.
17. Bezman, N. A., E. Cedars, D. F. Steiner, R. Blelloch, D. G. T. Hesslein, and L. L. Lanier. 2010. Distinct requirements of microRNAs in NK cell activation, survival, and function. J. Immunol. 185: 3835-3846.
18. Sullivan, R. P., J. W. Leong, S. E. Schneider, C. R. Keppel, E. Germino, A. R. French, and T. A. Fehniger. 2012. MicroRNA-deficient NK cells exhibit decreased survival but enhanced function. J. Immunol. 188: 3019-3030.
19. Thomas, M. F., S. Abdul-Wajid, M. Panduro, J. E. Babiarz, M. Rajaram, P. Woodruff, L. L. Lanier, V. Heissmeyer, and K. M. Ansel. 2012. Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function. Blood 120: 130-142.
20. Leong, J. W., R. P. Sullivan, and T. A. Fehniger. 2012. Natural killer cell regulation by microRNAs in health and disease. J. Biomed. Biotechnol. 2012: 632329.
21. Sullivan, R. P., J. W. Leong, and T. A. Fehniger. 2013. MicroRNA regulation of natural killer cells. Front Immunol 4: 44.
22. Beaulieu, A. M., N. A. Bezman, J. E. Lee, M. Matloubian, J. C. Sun, and L. L. Lanier. 2013. MicroRNA function in NK-cell biology. Immunol. Rev. 253: 40-52.
23. Trotta, R., L. Chen, D. Ciarlariello, S. Josyula, C. Mao, S. Costinean, L. Yu, J. P. Butchar, S. Tridandapani, C. M. Croce, and M. A. Caligiuri. 2012. miR-155 regulates IFN-γ production in natural killer cells. Blood 119: 3478-3485.
24. Trotta, R., L. Chen, S. Costinean, S. Josyula, B. L. Mundy-Bosse, D. Ciarlariello, C. Mao, E. L. Briercheck, K. K. McConnell, A. Mishra, et al. 2013. Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells. Blood 121: 3126-3134.
25. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
26. Thai, T.-H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
27. O'Connell, R. M., K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104: 1604-1609.
28. O'Connell, R. M., A. A. Chaudhuri, D. S. Rao, and D. Baltimore. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106: 7113-7118.
29. Fehniger, T. A., T. Wylie, E. Germino, J. W. Leong, V. J. Magrini, S. Koul, C. R. Keppel, S. E. Schneider, D. C. Koboldt, R. P. Sullivan, et al. 2010. Nextgeneration sequencing identifies the natural killer cell microRNA transcriptome. Genome Res. 20: 1590-1604.
30. Zawislak, C. L., A. M. Beaulieu, G. B. Loeb, J. Karo, D. Canner, N. A. Bezman, L. L. Lanier, A. Y. Rudensky, and J. C. Sun. 2013. Stage-specific regulation of natural killer cell homeostasis and response against viral infection by micro-RNA-155. Proc. Natl. Acad. Sci. USA 110: 6967-6972.
31. Eckelhart, E., W. Warsch, E. Zebedin, O. Simma, D. Stoiber, T. Kolbe, T. Rülicke, M. Mueller, E. Casanova, and V. Sexl. 2011. A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 117: 1565-1573.
32. Jonsson, H., L. Yang, S. Kim, S. M. Taffner, and W. M. Yokoyama. 2010. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184: 3424-3432.
33. van Rossum, H. H., F. P. H. T. M. Romijn, K. J. Sellar, N. P. M. Smit, P. J. M. van der Boog, J. W. de Fijter, and J. van Pelt. 2008. Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies. Clin. Chem. 54: 517-524.
34. Ortaldo, J. R., E. W. Bere, D. Hodge, and H. A. Young. 2001. Activating Ly-49 NK receptors: central role in cytokine and chemokine production. J. Immunol. 166: 4994-4999.
35. Bahner, I., T. Sumiyoshi, M. Kagoda, R. Swartout, D. Peterson, K. Pepper, F. Dorey, J. Reiser, and D. B. Kohn. 2007. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication. Mol. Ther. 15: 76-85.
36. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
37. Fogel, L. A., M. M. Sun, T. L. Geurs, L. N. Carayannopoulos, and A. R. French. 2013. Markers of nonselective and specific NK cell activation. J. Immunol. 190: 6269-6276.
38. Matkovich, S. J., D. J. Van Booven, W. H. Eschenbacher, and G. W. Dorn, II. 2011. RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ. Res. 108: 18-26.
39. Karginov, F. V., C. Conaco, Z. Xuan, B. H. Schmidt, J. S. Parker, G. Mandel, and G. J. Hannon. 2007. A biochemical approach to identifying microRNA targets. Proc. Natl. Acad. Sci. USA 104: 19291-19296.
40. Garcia, D. M., D. Baek, C. Shin, G. W. Bell, A. Grimson, and D. P. Bartel. 2011. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 18: 1139-1146.
41. Loeb, G. B., A. A. Khan, D. Canner, J. B. Hiatt, J. Shendure, R. B. Darnell, C. S. Leslie, and A. Y. Rudensky. 2012. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol. Cell 48: 760-770.
42. Banh, C., S. M. S. Miah, W. G. Kerr, and L. Brossay. 2012. Mouse natural killer cell development and maturation are differentially regulated by SHIP-1. Blood 120: 4583-4590.
43. Li, Q.-J., J. Chau, P. J. R. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.